Mesoblast Limited (MSB)

Index:

ASX 200

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.00
  • Currency: Australian Dollars
  • Shares Issued: 482.64m
Select chart: 1 month | 3 month | 6 month | 1 year
 

Current

1 month

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 96.28 (19.64) (12.37)¢ n/a n/a n/a n/a 0.0%
30-Jun-27 168.60 57.52 3.79¢ n/a n/a n/a n/a 0.0%
30-Jun-28 367.30 219.96 30.24¢ n/a n/a +697% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-26 $0.20 0.00
30-Jun-27 $0.35 0.00
30-Jun-28 $0.76 0.00

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2026 96 n/a 92 69 n/a 44
30-Jun-2027 169 n/a 194 216 n/a 242
30-Jun-2028 367 n/a 357 310 n/a n/a
 
Earnings
30-Jun-2026 n/a n/a n/a n/a n/a n/a
30-Jun-2027 3.79¢ n/a 3.54¢ n/a n/a 27.80¢
30-Jun-2028 30.24¢ n/a 29.92¢ 17.69¢ n/a n/a
 
Dividend
30-Jun-2026 n/a n/a n/a n/a n/a n/a
30-Jun-2027 n/a n/a n/a n/a n/a n/a
30-Jun-2028 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 2 0 1 0 0 1
Buy 4 0 4 0 4 2
Neutral 0 0 1 0 1 1
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 6 0 6 0 5 4
 
Average Rec 8.33 n/a 7.50 n/a 7.00 7.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

MSB Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.00
Shares Issued 482.64m

What The Brokers Say

Strong Buy 2
Buy 4
Neutral 0
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page